Go to:
Logótipo
Você está em: Start » Publications » View » Looking back on 20 years of work at the Porto Pharmacovigilance Centre, Portugal
Publication

Looking back on 20 years of work at the Porto Pharmacovigilance Centre, Portugal

Title
Looking back on 20 years of work at the Porto Pharmacovigilance Centre, Portugal
Type
Article in International Scientific Journal
Year
2021
Authors
Ribeiro Vaz, I
(Author)
FMUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Silva, AM
(Author)
FMUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Marques, J
(Author)
FMUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page Without ORCID
Polonia, J
(Author)
FMUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Journal
Vol. 37
ISSN: 0102-311X
Other information
Authenticus ID: P-00V-H84
Abstract (EN): Since 1963, the World Health Organization has acknowledged pharmacovigilance as a priority area in global public health, guaranteeing permanent monitoring of drug safety. This study aimed to characterize the reports of adverse drug reactions received by the Porto Pharmacovigilance Centre (UFPorto), Portugal, in the unit's two decades of work. The analysis included all reports of suspected adverse drug reactions received from January 2001 to December 2019. We calculated the annual reporting rates and distribution by origin, type of notifier and place of work, severity, prior knowledge, and causality of the reported adverse drug reactions. During the study period, UFPorto received 9,711 notifications of suspected adverse drug reactions. Hospital institutions reported the most suspected adverse drug reactions (n = 6,003; 64%), as did physicians among healthcare workers (n = 5,284; 54.4%). The most frequently reported adverse events were severe (n = 6,275; 72%) and are described in the respective Summary of Product Characteristics (n = 6,978; 72%). Most of the reports received by UFPorto were evaluated as having "probable" causality (n = 7,473; 77%), independently of the type of notifier. The results are consistent with other data previously reported in the international medical literature and official national reports. However, the underreporting rates are still higher than expected. In approximately 20 years, UFPorto has experienced an increase in its activity in various areas of drug safety.
Language: Portuguese
Type (Professor's evaluation): Scientific
No. of pages: 15
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same journal

Coffee and gastric cancer: Systematic review and meta-analysis (2006)
Another Publication in an International Scientific Journal
Botelho, F; Lunet N; Barros H
Biological and socio-cultural determinants of physical activity in adolescents (2008)
Another Publication in an International Scientific Journal
Andre F Seabra; Denisa M Mendonca; Martine A Thomis; Luiz A Anjos; Jose A Maia
Adverse drug reactions in patients with COVID-19 (2021)
Another Publication in an International Scientific Journal
Ferreira da Silva, R
Proteína C- reativa, atividade física e aptidão cardiorespiratória em adolescentes portugueses: Um estudo transversal (2015)
Article in National Scientific Journal
Agostini Sobrinho, CEsar Aparecido; Moreira, Carla Marisa Maia; Mota, Jorge Augusto Silva; Santos, Rute Marina Roberto dos
Walking, body mass index, and self-rated health in a representative sample of spanish adults (2016)
Article in International Scientific Journal
Vicente Romo-Perez; Dilia Souto; Jorge Mota

See all (35)

Recommend this page Top
Copyright 1996-2024 © Faculdade de Medicina da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z  I Guest Book
Page created on: 2024-08-28 at 21:31:31
Acceptable Use Policy | Data Protection Policy | Complaint Portal | Política de Captação e Difusão da Imagem Pessoal em Suporte Digital